Assay Protocol (PDF)DO NOT USE GLASSWARE FOR STANDARD DILUTION AND TRACER DILUTION.
Links to publications that use this kit:
Page et al. Intratesticular Androgens and Spermatogenesis During Severe Gonadotropin Suppression Induced by Male Hormonal Contraceptive Treatment. J Androl. 2007 Sep-Oct;28(5):734-41. Amory et al. Elevated End-of-Treatment Serum INSL3 Is Associated With Failure to Completely Suppress Spermatogenesis in Men Receiving Male Hormonal ContraceptionJ Androl. 2007 Jul-Aug;28(4):548-54. Novel Mutations Involving the INSL3 Gene Associated With CryptorchidismJ Urol. 2007 May;177(5):1947-51.
Page et al. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. J Clin Endocrinol Metab. 2006 Nov;91(11):4374-80.
Ferlin et al. Changes in Serum Insulin-Like Factor 3 during Normal Male PubertyJ Clin Endocrinol Metab. 2006 Sep;91(9):3426-31.
Ferlin et al. Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization.Mol Hum Reprod. 2006 Jun;12(6):401-6.
Foresta et al. Insulin-Like Factor 3: A Novel Circulating Hormone of Testis Origin in HumansJ Clin Endocrinol Metab. 2004 Dec;89(12):5952-8.
Bogatcheva et al. GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol Endocrinol. 2003 Dec;17(12):2639-46.
